{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:24:20Z","timestamp":1792592660429,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-119525"],"award-info":[{"award-number":["MOP-119525"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009408","name":"Fondation Brain Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003248","name":"Ontario Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012395","name":"Royal Bank of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bbi.2021.11.020","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T02:50:26Z","timestamp":1638931826000},"page":"278-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study"],"prefix":"10.1016","volume":"100","author":[{"given":"Sudhir","family":"Karthikeyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela K.","family":"Dimick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Fiksenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Birmaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Levitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory E.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayal","family":"Schaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Trevor","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Youngstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Andreazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin I.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2021.11.020_b0005","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), 4th ed. ed, American Psychiatric Press. American Psychiatric Association, Arlington, VA, DC. doi: 10.1176\/appi.books.9780890423349.","DOI":"10.1176\/appi.books.9780890423349"},{"issue":"4","key":"10.1016\/j.bbi.2021.11.020_b0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/104454603322724850","article-title":"A preliminary study of the Kiddie schedule for affective disorders and schizophrenia for school-age children mania rating scale for children and adolescents","volume":"13","author":"Axelson","year":"2003","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.bbi.2021.11.020_b0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40345-016-0055-3","article-title":"Does CRP predict outcome in bipolar disorder in regular outpatient care?","volume":"4","author":"Balukova","year":"2016","journal-title":"Int. J. Bipolar Disord."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.020_b0020","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1038\/tp.2013.87","article-title":"The association between immune activation and manic symptoms in patients with a depressive disorder","volume":"3","author":"Becking","year":"2013","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/camh.12021","article-title":"Bipolar disorder in children and adolescents","volume":"18","author":"Birmaher","year":"2013","journal-title":"Child Adolesc. Ment. Health"},{"key":"10.1016\/j.bbi.2021.11.020_b0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archpsyc.63.2.175","article-title":"Clinical course of children and adolescents with bipolar spectrum disorders","volume":"63","author":"Birmaher","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2021.11.020_b0035","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/appi.ajp.2009.08101569","article-title":"Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the course and outcome of bipolar youth (COBY) study","volume":"166","author":"Birmaher","year":"2009","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0040","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jad.2008.12.001","article-title":"Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder","volume":"116","author":"Brietzke","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.11.020_b0045","doi-asserted-by":"crossref","unstructured":"Buckley, L.F., Abbate, A., 2018. Interleukin-1 blockade in cardiovascular diseases: A clinical update. Eur. Heart J. 10.1093\/eurheartj\/ehy128.","DOI":"10.1093\/eurheartj\/ehy128"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0050","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5152\/npa.2015.8832","article-title":"Serum brain-derived neurotrophic factor levels among euthymic adolescents with bipolar disorder type I","volume":"53","author":"Cevher Binici","year":"2016","journal-title":"Noro Psikiyatr. Ars."},{"key":"10.1016\/j.bbi.2021.11.020_b0055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/archpsyc.1985.01790300064008","article-title":"The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version","volume":"42","author":"Chambers","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"issue":"02","key":"10.1016\/j.bbi.2021.11.020_b0060","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4088\/JCP.14r09007","article-title":"C-reactive protein alterations in bipolar disorder: a meta-analysis","volume":"76","author":"Darg\u00e9l","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.11.020_b0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/mp.2014.139","article-title":"Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass","volume":"20","author":"Davis","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.020_b0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neulet.2011.02.054","article-title":"Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: A preliminary 4-week study","volume":"494","author":"de Sousa","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2021.11.020_b0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40345-019-0162-z","article-title":"C-reactive protein concentration in bipolar disorder: association with genetic variants","volume":"7","author":"Evers","year":"2019","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.bbi.2021.11.020_b0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12916-015-0529-7","article-title":"Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies","volume":"13","author":"Fernandes","year":"2015","journal-title":"BMC Med."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.020_b0085","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S2215-0366(16)30370-4","article-title":"C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis","volume":"3","author":"Fernandes","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2021.11.020_b0090","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/0004867413478217","article-title":"Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force","volume":"47","author":"Frey","year":"2013","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.020_b0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pbb.2018.12.006","article-title":"Revisiting inflammation in bipolar disorder","volume":"177","author":"Fries","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2021.11.020_b0100","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archpsyc.65.10.1125","article-title":"Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome","volume":"65","author":"Geller","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1017\/S0033291708003723","article-title":"Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-Year follow-up of the Whitehall II study","volume":"39","author":"Gimeno","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2021.11.020_b0110","doi-asserted-by":"crossref","unstructured":"Goldsmith, D.R., Rapaport, M.H., Miller, B.J., 2016. A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression, in: Molecular Psychiatry. Nature Publishing Group, pp. 1696\u20131709. 10.1038\/mp.2016.3.","DOI":"10.1038\/mp.2016.3"},{"issue":"5","key":"10.1016\/j.bbi.2021.11.020_b0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/cap.2011.0009","article-title":"Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders","volume":"21","author":"Goldstein","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"12","key":"10.1016\/j.bbi.2021.11.020_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-013-0425-9","article-title":"Toward clinically applicable biomarkers in bipolar disorder: Focus on BDNF, inflammatory markers, and endothelial function","volume":"15","author":"Goldstein","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.020_b0125","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/CIR.0000000000000229","article-title":"Major depressive disorder and bipolar disorder predispose youth to accelerated atherosclerosis and early cardiovascular disease","volume":"132","author":"Goldstein","year":"2015","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.bbi.2021.11.020_b0130","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.4088\/JCP.14m09395","article-title":"Inflammatory markers among adolescents and young adults with bipolar spectrum disorders","volume":"76","author":"Goldstein","year":"2015","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2021.11.020_b0135","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/bdi.12921","article-title":"Call to action regarding the vascular-bipolar link: a report from the Vascular Task Force of the International Society for Bipolar Disorders","volume":"22","author":"Goldstein","year":"2020","journal-title":"Bipolar Disord."},{"issue":"9783","key":"10.1016\/j.bbi.2021.11.020_b0140","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(11)60512-6","article-title":"Global burden of disease in young people aged 10\u201324 years: a systematic analysis","volume":"377","author":"Gore","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.bbi.2021.11.020_b0145","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jpsychires.2012.08.017","article-title":"Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: an open-label trial in drug-free patients with bipolar disorder","volume":"46","author":"Grande","year":"2012","journal-title":"J. Psychiatr. Res."},{"issue":"25","key":"10.1016\/j.bbi.2021.11.020_b0150","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1161\/CIR.0b013e3182051bab","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of cardiology foundation\/American Heart association task force on practice guidelines","volume":"122","author":"Greenland","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0155","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.4088\/JCP.16m10762","article-title":"Inflammatory markers and brain-derived neurotrophic factor as potential bridges linking bipolar disorder and cardiovascular risk among adolescents","volume":"78","author":"Hatch","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.020_b0160","series-title":"Four factor index of social status","author":"Hollingshead","year":"1975"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0165","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/bdi.12164","article-title":"Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study","volume":"16","author":"Hsu","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.bbi.2021.11.020_b0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2016.03.040","article-title":"Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study","volume":"197","author":"Jacoby","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.11.020_b0175","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2014.13880","article-title":"Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study","volume":"144","author":"Kargar","year":"2014","journal-title":"Swiss Med. Wkly"},{"issue":"6","key":"10.1016\/j.bbi.2021.11.020_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijdevneu.2007.07.002","article-title":"Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls","volume":"25","author":"Katoh\u2010Semba","year":"2007","journal-title":"Int. J. Dev. Neurosci."},{"issue":"7","key":"10.1016\/j.bbi.2021.11.020_b0185","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.020_b0190","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/archpsyc.1987.01800180050009","article-title":"The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies","volume":"44","author":"Keller","year":"1987","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2021.11.020_b0195","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s40263-014-0158-2","article-title":"PPAR-\u03b3 agonism as a modulator of mood: Proof-of-concept for pioglitazone in bipolar depression","volume":"28","author":"Kemp","year":"2014","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0200","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jacc.2005.04.051","article-title":"Race and gender differences in C-reactive protein levels","volume":"46","author":"Khera","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.bbi.2021.11.020_b0205","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/sj.mp.4001084","article-title":"The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: Effects of psychotropic drugs","volume":"7","author":"Kim","year":"2002","journal-title":"Mol. Psychiatry"},{"issue":"1-3","key":"10.1016\/j.bbi.2021.11.020_b0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jad.2007.02.018","article-title":"Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder","volume":"104","author":"Kim","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.11.020_b0215","doi-asserted-by":"crossref","unstructured":"Kishi, T., Yoshimura, R., Ikuta, T., Iwata, N., 2018. Brain-derived neurotrophic factor and major depressive disorder: Evidence from meta-analyses. Front. Psychiatry. doi: 10.3389\/fpsyt.2017.00308.","DOI":"10.3389\/fpsyt.2017.00308"},{"key":"10.1016\/j.bbi.2021.11.020_b0220","first-page":"268","article-title":"Serum levels of IL-6, IL-10 and TNF-a in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance","volume":"33","author":"Kunz","year":"2011","journal-title":"Rev. Bras. Psiquiatr."},{"issue":"6","key":"10.1016\/j.bbi.2021.11.020_b0225","doi-asserted-by":"crossref","first-page":"e66847","DOI":"10.1371\/journal.pone.0066847","article-title":"Inflammation\u2019s association with metabolic profiles before and after a twelve-week clinical trial in drug-na\u00efve patients with bipolar II disorder","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.bbi.2021.11.020_b0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jneuroim.2004.01.006","article-title":"Immunologic variables in acute mania of bipolar disorder","volume":"150","author":"Liu","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.020_b0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","article-title":"The impact of age, weight and gender on BDNF levels in human platelets and plasma","volume":"26","author":"Lommatzsch","year":"2005","journal-title":"Neurobiol. Aging"},{"issue":"12","key":"10.1016\/j.bbi.2021.11.020_b0240","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1007\/s12035-018-1016-x","article-title":"The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder","volume":"55","author":"Maes","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2021.11.020_b0245","doi-asserted-by":"crossref","unstructured":"Marshe, V.S., Pira, S., Mantere, O., Bosche, B., Looper, K.J., Herrmann, N., M\u00fcller, D.J., Rej, S., 2017. C-reactive protein and cardiovascular risk in bipolar disorder patients: A systematic review. Prog. Neuro-Psychopharmacology Biol. Psychiatry. 10.1016\/j.pnpbp.2017.07.026.","DOI":"10.1016\/j.pnpbp.2017.07.026"},{"key":"10.1016\/j.bbi.2021.11.020_b0250","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.psychres.2016.04.120","article-title":"Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders","volume":"241","author":"Miklowitz","year":"2016","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.020_b0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biopsych.2013.01.007","article-title":"Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies","volume":"74","author":"Modabbernia","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2021.11.020_b0260","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jpsychires.2013.05.018","article-title":"Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis","volume":"47","author":"Munkholm","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"1-2","key":"10.1016\/j.bbi.2021.11.020_b0265","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jad.2012.06.010","article-title":"Cytokines in bipolar disorder: a systematic review and meta-analysis","volume":"144","author":"Munkholm","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.11.020_b0270","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbi.2014.09.021","article-title":"Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients","volume":"43","author":"Munkholm","year":"2015","journal-title":"Brain. Behav. Immun."},{"issue":"1-3","key":"10.1016\/j.bbi.2021.11.020_b0275","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.schres.2006.05.028","article-title":"Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients","volume":"86","author":"Palomino","year":"2006","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.bbi.2021.11.020_b0280","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/CHI.0b013e31817eecd9","article-title":"Brain-derived neurotrophic factor gene expression in pediatric bipolar disorder: effects of treatment and clinical response","volume":"47","author":"Pandey","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"12","key":"10.1016\/j.bbi.2021.11.020_b0285","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jpsychires.2006.09.009","article-title":"Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications","volume":"41","author":"Post","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2021.11.020_b0290","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jad.2021.05.062","article-title":"Lower pro- to anti-inflammatory ratios associated with reduced neurocognitive flexibility in symptomatic adolescents with bipolar disorder","volume":"292","author":"Rahmani","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2021.11.020_b0295","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-3956(99)00007-2","article-title":"Immune parameters in rapid cycling bipolar patients before and after lithium treatment","volume":"33","author":"Rapaport","year":"1999","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000339949","article-title":"Selected cytokine profiles during remission in bipolar patients","volume":"66","author":"Remlinger-Molenda","year":"2012","journal-title":"Neuropsychobiology"},{"issue":"1","key":"10.1016\/j.bbi.2021.11.020_b0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From c-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bbi.2021.11.020_b0310","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.psc.2015.09.006","article-title":"Bipolar disorder and inflammation","volume":"39","author":"Rosenblat","year":"2016","journal-title":"Psychiatr. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0315","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1192\/bjp.2018.144","article-title":"Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses","volume":"213","author":"Rowland","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.020_b0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/oby.2000.86","article-title":"Raised interleukin-6 levels in obese patients","volume":"8","author":"Roytblat","year":"2000","journal-title":"Obes. Res."},{"key":"10.1016\/j.bbi.2021.11.020_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychires.2017.03.018","article-title":"A systemic review of evidence for the role of inflammatory biomarkers in bipolar patients","author":"Sayana","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2021.11.020_b0330","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jad.2015.12.020","article-title":"Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder","volume":"192","author":"Scola","year":"2016","journal-title":"J. Affect. Disord."},{"issue":"4","key":"10.1016\/j.bbi.2021.11.020_b0335","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/014572170403000412","article-title":"Quick WAVE screener: a tool to address weight, activity, variety, and excess","volume":"30","author":"Soroudi","year":"2004","journal-title":"Diabetes Educ."},{"key":"10.1016\/j.bbi.2021.11.020_b0340","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pnpbp.2017.08.024","article-title":"Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts","volume":"81","author":"Sowa-Ku\u0107ma","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.11.020_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.020_b0350","doi-asserted-by":"crossref","first-page":"E433","DOI":"10.1152\/ajpendo.00074.2003","article-title":"IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans","volume":"285","author":"Steensberg","year":"2003","journal-title":"Am. J. Physiol. \u2013 Endocrinol. Metab."},{"issue":"1-3","key":"10.1016\/j.bbi.2021.11.020_b0355","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0165-0327(01)00369-X","article-title":"Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission","volume":"71","author":"Su","year":"2002","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.bbi.2021.11.020_b0360","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00702-014-1162-x","article-title":"Altered peripheral BDNF mRNA expression and BDNF protein concentrations in blood of children and adolescents with autism spectrum disorder","volume":"121","author":"Taurines","year":"2014","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.1016\/j.bbi.2021.11.020_b0365","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2009.01.028","article-title":"Brain-derived neurotrophic factor serum levels before and after treatment for acute mania","volume":"452","author":"Tramontina","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bbi.2021.11.020_b0370","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.psychres.2015.05.078","article-title":"Assessment of cytokine levels and hs-CRP in bipolar I disorder before and after treatment","volume":"228","author":"Uyanik","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2021.11.020_b0375","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archpsyc.57.7.675","article-title":"Brief screening for family psychiatric history: the family history screen","volume":"57","author":"Weissman","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.11.020_b0380","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1192\/bjp.bp.114.150870","article-title":"Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population","volume":"208","author":"Wium-Andersen","year":"2016","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2021.11.020_b0385","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.pnpbp.2009.12.003","article-title":"Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression","volume":"34","author":"Yoshimura","year":"2010","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2021.11.020_b0390","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.neurobiolaging.2006.06.011","article-title":"Serum neurotrophins-A study on the time course and influencing factors in a large old age sample","volume":"28","author":"Ziegenhorn","year":"2007","journal-title":"Neurobiol. Aging"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121006243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121006243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:17:55Z","timestamp":1760170675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121006243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":78,"alternative-id":["S0889159121006243"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.11.020","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory markers, brain-derived neurotrophic factor, and the symptomatic course of adolescent bipolar disorder: A prospective repeated-measures study","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}